Sai Parenterals Stock Performance

as on July 3, 2026 at 9:31 pm IST

Day's Low
Day's High
₹613.70
Day's Price Range
₹633.15
₹618.60
0.79%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
₹400.00
52-Week Price Range
₹633.15
₹618.60
35.34%
Downside
2.35%
Upside

Sai Parenterals share price movements today

Previous Close: ₹623.80
Open: ₹625.00
Volume: 2.83L
Upper Circuit: ₹748.55
Lower Circuit: ₹499.05
Day's Low - High: ₹613.70 - ₹633.15
52 Week Low - High: ₹400.00 - ₹633.15

Sai Parenterals Historical Returns

1 Month Return: + 24.86 %
3 Month Return: + 53.4 %
1 Year Return: + 53.76 %
3 Year Return: + 53.76 %
5 Year Return: + 53.76 %

Sai Parenterals Fundamentals

as on July 3, 2026 at 4:01 pm IST

Market Cap

₹2,755.90 Cr

Return on Equity (ROE)

12.21

PE Ratio (TTM)

Return on capital employed (ROCE)

13.87

Beta (LTM)

0.54

P/B Ratio

Dividend Yield

PEG Ratio

Quarterly Earnings Growth YOY

EPS (TTM)

Book Value

Sai Parenterals Technical Analysis

Track how Sai Parenterals technical analysis has moved over time to understand its trends.

1 min

5 min

15 min

30 min

1 day

Technicals Summary

Bearish

Neutral

Bullish

Moving Averages

Bearish

Neutral

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish3

Bullish10

Neutral2

Oscillators

Name	Value	Action
MACD level (12,26)	0.43	Bullish
CCI (20)	298.4	Bearish
RSI (14)	55.86	Neutral
Momentum (10)	1.1	Bearish
ADI (14)	26.74	Bullish
Ultimate Oscillator (7,14,28)	50.36	Neutral

Moving Averages

Name	Value	Action
SMA (20)	619.17	Bullish
EMA (20)	619.43	Bullish
VWMA (20)	619.54	Bullish
SMA (50)	618.6	Bullish
EMA (50)	619.19	Bullish
SMA (200)	620.42	Bearish
EMA (200)	619.94	Bullish
KAMA (200)	618.69	Bullish
DEMA (200)	619.13	Bullish

Sai Parenterals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sai Parenterals with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Sai Parenterals Ltd	NA	2,755.90	10.75%	0.75	14	163
Sunrest Lifescience Ltd	NA	29.18	-11.48%	0.00	2	33
Cohance Lifesciences Ltd	HOLD	17,314.99	-1.31%	0.68	264	1,197
Pentokey Organy (India) Ltd	NA	0.00	20.69%	0.00	3	4
Amrutanjan Health Care Ltd	NA	1,568.55	-4.85%	0.00	NA	NA

See all

Sai Parenterals Stock’s Investor Sentiment and Interest

Investment in Sai Parenterals Ltd Shares on INDmoney has grown by 190.28% over the past 30 days, indicating increased transactional activity.

Time period: June 4, 2026 to July 4, 2026

Change:190.28% versus previous 30 day period

Search interest for Sai Parenterals Ltd Stock has increased by 127% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 4, 2026 to July 4, 2026

Change:127% versus previous 30 day period

Sai Parenterals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

	Dec 2025	Mar 2026
Sales	96.15	197.93
Other Income	3.13	2.88
Total Income	99.28	200.81
Expenses	99.71	171.84
Operating Profit	-3.56	26.09
Operating Profit Margin %	-3.7%	13.18%
Profit Before Interest, Tax and Depreciation	-0.43	28.97
Interest	5.41	8.4
Depreciation	5.79	8.18
Profit Before Tax	-11.63	12.39
Tax Paid	-4.96	-0.76
Profit After Tax	-6.66	13.16
Total Net profit including share of profit / Loss from associate company	-6.66	13.16
EPS	-2.22	4.02
Actual EPS	-2.22	4.02
Adjusted EPS	-2.22	4.02
Diluted EPS	-2.22	4.02

Sai Parenterals Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	96.8	153.76	163.11	381
Other Income	0.23	1.42	0.64	8.52
Total Income	97.03	155.18	163.74	389.52
Expenses	79.17	122.1	123.72	342.3
Operating Profit	17.63	31.66	39.39	38.7
Operating Profit Margin %	18.21%	20.59%	24.15%	10.16%
Profit Before Interest, Tax and Depreciation	17.86	33.08	40.02	47.22
Interest	4.81	11.11	11.91	18.44
Depreciation	5.79	9.42	8.2	16.85
Profit Before Tax	7.26	12.55	19.91	11.93
Tax Paid	2.88	4.14	5.49	-2.34
Profit After Tax	4.38	8.42	14.43	14.26
Total Net profit including share of profit / Loss from associate company	4.38	8.42	14.43	14.26
EPS	6.16	63.51	108.4	4.36
Actual EPS	6.16	63.51	108.4	4.36
Adjusted EPS	3.08	31.76	108.4	4.36
Diluted EPS	6.16	63.51	108.4	4.36

Sai Parenterals Ltd Cash Flow

Figures in Rupees Crores

	Mar 2023	Mar 2024	Mar 2025
Net Cash from Operating Activities	-12.8	-29.76	33.15
Cash Flow from Investing Activities	-19.03	-47.92	0.93
Cash Flow from Financing Activities	23.99	78.57	-35.89
Net Cash Flow	-7.85	2.48	-2.3

Sai Parenterals Stock Shareholding Pattern

Numbers in percentages

	Sep 2025	Mar 2026	Apr 2026
Promoters	61.23%	51.16%	51.16%
DII	0%	12.86%	12.86%
FII	0%	5.73%	5.73%
Public	0%	30.26%	30.26%
Total Outstanding Shares	3,69,08,823	4,41,79,231	4,41,79,231
Total Shareholders	119	7,687	7,687

Mutual Funds that own Sai Parenterals Stock

Check out the Mutual Funds with significant holdings in Sai Parenterals.

Funds	Holdings	Shares Held
Quant Momentum Fund Direct Growth	3.02%	844112
Quant Small Cap Fund Growth Option Direct Plan	0.05%	311056

Indices Featuring Sai Parenterals Stock

Check stock indices that include Sai Parenterals.

BSE IPO

₹17,671.87

-85.91 (▲0.48%)

Insights on Sai Parenterals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, SAIPARENT stock has moved up by 6.2%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.16% of holdings in Apr 2026 quarter
NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 5.73% of holdings in Apr 2026 quarter
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 30.26% of holdings in Apr 2026 quarter

About Sai Parenterals Ltd

Sai Parenterals Limited was originally incorporated as Sai Parenterals Private Limited a Private Limited Company on January 12 2001 with the Registrar of Companies at Hyderabad. Thereafter Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenterals Limited w.e.f January 17 2022.Sai Parenterals is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization CDMO products and services for the domestic and international markets. Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products covering both highvalue and highvolume categories addressing critical therapeutic needs across the multiple disease areas. The key therapeutic areas include cardiovascular neuropsychiatry antidiabetic respiratory health antibiotics gastroenterology vitamins minerals and supplements VMS analgesics and dermatology products in dosage forms such as injectables tablets capsules liquid orals and ointments.The Company acquired UnitI and UnitII in 2016. It launched Prefilled technology equipment at UnitI in FY 2021. Company has undertaken strategic acquisitions that expanded the manufacturing technological and CDMO capabilities diversified the product range and increased geographical presence in regulated and semi regulated markets.In February 2022 Company acquired Unit III facility located at IDA Bhongir Hyderabad and accredited by the Therapeutic Goods Administration TGA Australia. In September 2022 Company acquired Unit IV facility accredited with Pharmaceutical Inspection Cooperation Scheme PIC/S and WHOGMP. It started the export business in 2023 after acquiring two internationally accredited manufacturing units in Hyderabad Telangana. In February 2024 Company further expanded its domestic presence by making Revat Laboratories as a wholly owned subsidiary. The Company has incorporated a wholly owned subsidiary Sai Parenterals Pte. Limited in Singapore in FY25. Company is planning the Initial Public Offer by issuing 3500000 equity shares having the face value of Rs 5 each through Offer for Sale and by raising Rs 285 Cr equity shares through Fresh Issue..

Revenue: ₹197.93Cr as on March 2026 (Q4 FY26)
Net Profit: ₹13.16Cr as on March 2026 (Q4 FY26)
Listing date: 02 Apr, 2026
Chairperson Name: ANIL KUMAR KARUSALA

Organisation	Sai Parenterals Ltd
Industry	Pharmaceuticals
CEO	ANIL KUMAR KARUSALA
E-voting on shares	Click here to vote

FAQs

What is Sai Parenterals share price today?

Sai Parenterals share price today stands at ₹618.6 as on July 3, 2026 at 4:01 pm IST at the close of the market. Sai Parenterals share today touched a day high of ₹633.15 and a low of ₹613.7.

What is the 52 week high and 52 week low range for Sai Parenterals share?

Sai Parenterals touched a 52 week high of ₹633.15 and a 52 week low of ₹400. Sai Parenterals share price today i.e. July 3, 2026 at 4:01 pm IST is closed at ₹618.6, which is -2.30% down from its 52 week high and 54.65% up from its 52 week low.

What is Sai Parenterals's market capitalisation today?

Sai Parenterals market capitalisation is ₹2,755.90 Cr as on July 3, 2026 at 4:01 pm IST.

How to buy Sai Parenterals shares?

To buy Sai Parenterals shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for SAIPARENT or Sai Parenterals Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Sai Parenterals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sai Parenterals trading volume today?

Sai Parenterals trading volume is 2.83L as on July 3, 2026 at 4:01 pm IST. This means that 2.83L shares of Sai Parenterals were bought and sold on the stock market during today's trading session.